Article citationsMore>>
Katsumata, N., Yasuda, M., Isonishi, S., Takahashi, F., Michimae, H., Kimura, E., et al. (2013) Long-Term Results of Dose-Dense Paclitaxel and Carboplatin versus Conventional Paclitaxel and Carboplatin for Treatment of Advanced Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer (JGOG 3016): A Randomised, Controlled, Open-Label Trial. The Lancet Oncology, 14, 1020-1026.
http://dx.doi.org/10.1016/S1470-2045(13)70363-2
has been cited by the following article:
-
TITLE:
Current Possible Drug Therapies for Ovarian Cancer
AUTHORS:
Jungyeob Seoung, Young-Han Park, Chaechun Rhim, Sungju Kim
KEYWORDS:
Ovarian Cancer, Intraperitoneal Chemotherapy, Targeting Therapy
JOURNAL NAME:
Journal of Cancer Therapy,
Vol.5 No.13,
November
7,
2014
ABSTRACT:
Ovarian cancer is the most aggressive
gynecologic cancer of the heterogenous phenotypes. Development of the new
chemotherapeutic agents and drug delivery mode makes better outcomes for
patient treatments. Optimal cytoreductive therapy followed by molecular
targeting therapy, intraperitoneal chemotherapy and dose dense chemotherapy is
a hot therapeutic concept in ovarian cancers. In our review, we will introduce
recent therapeutic advances in epithelial ovarian cancer patients.
Related Articles:
-
Takanori Ayabe, Masaki Tomita, Eiichi Chosa, Makoto Ikenoue, Yukie Shirasaki, Kunihide Nakamura
-
A. Mounir, E. E. Ibrahim
-
Shimaa Ahmed, Mayada Fawzy, Khalid Rezk, Wessam Elshrif, Mohamed Alaa, Mohamed M. H. Abd Ellah
-
Hiroshi Takagi, Satoshi Ichigo, Kazutoshi Matsunami, Haruna Takagi, Tsuneko Ikeda, Takayuki Murase, Atsushi Imai
-
Farhana Kalam, Shahana Pervin, K. M. Nazmul Islam Joy, Johirul Islam, Annekathryn Goodman